Sandbox brain abscess: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
m (Changes made per Mahshid's request)
 
(14 intermediate revisions by one other user not shown)
Line 7: Line 7:


==Antimicrobial Therapy – Empiric Therapy==
==Antimicrobial Therapy – Empiric Therapy==
 
{{rx|Preferred regimen}}
=====Preferred regimen=====
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}}
{{abx|Cefotaxime 8–12 g/day q4–6h|Ceftriaxone 4 g/day q12h}} {{and}} {{abx|Metronidazole 30 mg/kg/day q6h}}
* [[Metronidazole]] 30 mg/kg/day q6h
 
</li>
=====Alternative regimen=====
{{rx|Alternative regimen}}
{{abx|Meropenem 6 g/day q8h}}
* [[Meropenem]] 6 g/day q8h
 
</li>
====Transplant recipients====
{{rx|Transplant recipients}}
{{abx|Cefotaxime 8–12 g/day q4–6h|Ceftriaxone 4 g/day q12h}} {{and}} {{abx|Metronidazole 30 mg/kg/day q6h}} {{and}} {{abx|Voriconazole 8 mg/kg/day q12h}} {{and}} {{abx|TMP-SMZ 10–20 mg/kg/day q6–12h|Sulfadiazine 4–6 g/day q6h}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}}
 
* [[Metronidazole]] 30 mg/kg/day q6h {{and}}
====Patients with HIV/AIDS====
* [[Voriconazole]] 8 mg/kg/day q12h {{and}}
{{abx|Cefotaxime 8–12 g/day q4–6h|Ceftriaxone 4 g/day q12h}} {{and}} {{abx|Metronidazole 30 mg/kg/day q6h}} {{and}} {{abx|Sulfadiazine 4–6 g/day q6h}} {{and}} {{abx|Pyrimethamine 25–100 mg/day qd}}
* [[TMP-SMZ]] 10–20 mg/kg/day q6–12h {{or}} [[Sulfadiazine]] 4–6 g/day q6h
 
</li>
====''Staphylococcus aureus'' coverage====
{{rx|Patients with HIV/AIDS}}
{{abx|Vancomycin 30–45 mg/kg/day q8–12h}}
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h {{and}}
 
* [[Sulfadiazine]] 4–6 g/day q6h {{and}}
====''Mycobacterium tuberculosis'' coverage====
* [[Pyrimethamine]] 25–100 mg/day qd
{{abx|Vancomycin 30–45 mg/kg/day q8–12h}} {{and}} {{abx|Isoniazid 300 mg qd}} {{and}} {{abx|Rifampin 600 mg qd}} {{and}} {{abx|Pyrazinamide 15–30 mg qd}} {{and}} {{abx|Ethambutol 15 mg/kg/day qd}}
</li>
{{rx|Staphylococcus aureus coverage}}
* [[Vancomycin]] 30–45 mg/kg/day q8–12h
</li>
{{rx|Mycobacterium tuberculosis coverage}}
* [[Isoniazid]] 300 mg qd {{and}}
* [[Rifampin]] 600 mg qd {{and}}
* [[Pyrazinamide]] 15–30 mg qd {{and}}
* [[Ethambutol]] 15 mg/kg/day qd
</li>


==Antimicrobial Therapy – Pathogen-Based Therapy==
==Antimicrobial Therapy – Pathogen-Based Therapy==
 
{{rx|Actinomyces}}
====''Actinomyces''====
* [[Penicillin G]] 24 MU q4h
{{abx|Penicillin G 24 MU q4h}}
</li>
 
{{rx|Bacteroides fragilis}}
====''Bacteroides fragilis''====
* [[Metronidazole]] 30 mg/kg/day q6h
{{abx|Metronidazole 30 mg/kg/day q6h}}
</li>
 
{{rx|Enterobacteriaceae}}
====''Enterobacteriaceae''====
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h
{{abx|Cefotaxime 8–12 g/day q4–6h|Ceftriaxone 4 g/day q12h}}
</li>
 
{{rx|Fusobacterium}}
====''Fusobacterium''====
* [[Metronidazole]] 30 mg/kg/day q6h
{{abx|Metronidazole 30 mg/kg/day q6h}}
</li>
 
{{rx|Haemophilus}}
====''Haemophilus''====
* [[Cefotaxime]] 8–12 g/day q4–6h {{or}} [[Ceftriaxone]] 4 g/day q12h
{{abx|Cefotaxime 8–12 g/day q4–6h|Ceftriaxone 4 g/day q12h}}
</li>
 
{{rx|Listeria monocytogenes}}
====''Listeria monocytogenes''====
* [[Ampicillin]] 12 g/day q4h {{or}} [[Penicillin G]] 24 MU q4h
{{abx|Ampicillin 12 g/day q4h|Penicillin G 24 MU q4h}}
</li>
 
{{rx|Nocardia}}
====''Nocardia''====
* [[TMP-SMZ]] 10–20 mg/kg/day q6–12h {{or}} [[Sulfadiazine]] 4–6 g/day q6h
{{abx|TMP-SMZ 10–20 mg/kg/day q6–12h|Sulfadiazine 4–6 g/day q6h}}
</li>
 
{{rx|Prevotella melaninogenica}}
====''Prevotella melaninogenica''====
* [[Metronidazole]] 30 mg/kg/day q6h
{{abx|Metronidazole 30 mg/kg/day q6h}}
</li>
 
{{rx|Pseudomonas aeruginosa}}
====''Pseudomonas aeruginosa''====
* [[Ceftazidime]] 6 g/day q8h {{or}} [[Cefepime]] 6 g/day q8h
{{abx|Ceftazidime 6 g/day q8h|Cefepime 6 g/day q8h}}
</li>
 
{{rx|Methicillin-sensitive Staphylococcus aureus}}
====Methicillin-Sensitive ''Staphylococcus aureus''====
* [[Nafcillin]] 12 g/day q4h {{or}} [[Oxacillin]] 12 g/day q4h
{{abx|Nafcillin 12 g/day q4h|Oxacillin 12 g/day q4h}}
</li>
 
{{rx|Methicillin-resistant Staphylococcus aureus}}
====Methicillin-resistant ''Staphylococcus aureus''====
* [[Vancomycin]] 30–45 mg/kg/day q8–12h
{{abx|Vancomycin 30–45 mg/kg/day q8–12h}}
</li>
 
{{rx|Streptococcus anginosus and other streptococci}}
====''Streptococcus anginosus'' and other ''Streptococci''====
* [[Penicillin G]] 24 MU q4h
{{abx|Penicillin G 24 MU q4h}}
</li>
 
{{rx|Aspergillus}}
====''Aspergillus''====
* [[Voriconazole]] 8 mg/kg/day q12h
{{abx|Voriconazole 8 mg/kg/day q12h}}
</li>
 
{{rx|Candida}}
====''Candida''====
* [[Amphotericin B]] lipid complex 5 mg/kd/day q24h {{or}} [[Amphotericin B]] deoxycholate 15 mg/kg/day q8h
{{abx|Amphotericin B lipid complex 5 mg/kd/day q24h|Amphotericin B deoxycholate 15 mg/kg/day q8h}}
</li>
 
{{rx|Cryptococcus neoformans}}
====''Cryptococcus neoformans''====
* [[Amphotericin B]] lipid complex 5 mg/kd/day q24h {{or}} [[Amphotericin B]] deoxycholate 15 mg/kg/day q8h
{{abx|Amphotericin B lipid complex 5 mg/kd/day q24h|Amphotericin B deoxycholate 15 mg/kg/day q8h}}
</li>
 
{{rx|Mucorales}}
====''Mucorales''====
* [[Amphotericin B]] lipid complex 5 mg/kd/day q24h {{or}} [[Amphotericin B]] deoxycholate 15 mg/kg/day q8h
{{abx|Amphotericin B lipid complex 5 mg/kd/day q24h|Amphotericin B deoxycholate 15 mg/kg/day q8h}}
</li>
 
{{rx|Pseudallescheria boydii (Scedosporium apiospermum)}}
====''Pseudallescheria boydii (Scedosporium apiospermum)''====
* [[Voriconazole]] 8 mg/kg/day q12h
{{abx|Voriconazole 8 mg/kg/day q12h}}
</li>
 
{{rx|Toxoplasma gondii}}
====''Toxoplasma gondii''====
* [[Sulfadiazine]] 4–6 g/day q6h {{and}}
{{abx|Sulfadiazine 4–6 g/day q6h}} {{and}} {{abx|Pyrimethamine 25–100 mg/day qd}}
* [[Pyrimethamine]] 25–100 mg/day qd
</li>


==References==
==References==
Line 87: Line 97:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Infectious disease]]
 
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]

Latest revision as of 18:41, 18 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Abscess Main Page

Brain abscess Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brain abscess from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox brain abscess On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox brain abscess

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox brain abscess

CDC on Sandbox brain abscess

Sandbox brain abscess in the news

Blogs on Sandbox brain abscess

Directions to Hospitals Treating Brain abscess

Risk calculators and risk factors for Sandbox brain abscess

Overview

Treatment of brain abscess requires a multidisciplinary approach to delineate extent of infection, plan stereotactic trajectory, aspirate purulent materials, lower intracranial pressure, identify causative pathogen, and administer appropriate antibiotics.

Antimicrobial Therapy – Empiric Therapy

  • Antimicrobial Therapy – Pathogen-Based Therapy

  • References